LataMed AI Provides Shareholder Update on Upcoming 5-for-1 Forward Stock Split and Mandatory Share Exchange

LataMed AI Corp. (OTC: LMED) provided shareholders with an update on the implementation of its previously announced 5-for-1 forward stock split and mandatory share exchange process. As of July 7, 2026, the company has submitted all required information to FINRA, and management anticipates the corporate action may become effective within approximately the next week, subject to FINRA's review and processing.

The forward stock split will be accompanied by a new CUSIP number, 21116R404, to facilitate the mandatory exchange. Shareholders holding shares through brokerage accounts will generally have their shares updated automatically. Similarly, registered book-entry shareholders need not take action, as the transfer agent will update accounts. Physical certificate holders are not required to surrender certificates immediately, but when they submit them for transfer or sale, the certificates will be processed under the new CUSIP.

Dr. Kevin Rodan Levy, CEO, emphasized the importance of clear guidance for shareholders, particularly those with physical certificates. He stated that post-split, management will focus on advancing the telemedicine platform and pursuing licensing opportunities for CardioAI, PulmoAI, and NeuroAI platforms, which are integral to building an integrated digital healthcare ecosystem in Latin America.

This corporate action supports LataMed's capital structure and strategic initiatives. The company encourages shareholders to contact their brokers or the transfer agent for further details. Additional updates will be provided as the effective date approaches. For more information, visit https://latamed.ai or review SEC filings at www.sec.gov.